Differential effects of primary disease and corneal vascularisation on corneal transplant rejection and survival
暂无分享,去创建一个
S. Tuft | D. Larkin | S. Kaye | C. Hopkinson | D. Sibley
[1] A. Penman,et al. Effectiveness of Histocompatibility Matching in High-Risk Corneal Transplantation , 2020 .
[2] D. Larkin,et al. Longitudinal changes in corneal leucocyte density in vivo following transplantation , 2018, British Journal of Ophthalmology.
[3] N. Gupta,et al. Lymphatic vessels identified in failed corneal transplants with neovascularisation , 2018, British Journal of Ophthalmology.
[4] T. Clahsen,et al. Photodynamic Therapy Leads to Time-Dependent Regression of Pathologic Corneal (Lymph) Angiogenesis and Promotes High-Risk Corneal Allograft Survival. , 2017, Investigative ophthalmology & visual science.
[5] D. Larkin,et al. The Influence of Donor and Recipient Gender Incompatibility on Corneal Transplant Rejection and Failure , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[6] R. Dana,et al. Alloimmunity and Tolerance in Corneal Transplantation , 2016, The Journal of Immunology.
[7] Gilles Thuret,et al. Global Survey of Corneal Transplantation and Eye Banking. , 2016, JAMA ophthalmology.
[8] Yalin Zheng,et al. Angiographic and In Vivo Confocal Microscopic Characterization of Human Corneal Blood and Presumed Lymphatic Neovascularization: A Pilot Study , 2015, Cornea.
[9] H. Dua,et al. Clinical evaluation and characterisation of corneal vascularisation , 2015, British Journal of Ophthalmology.
[10] Yalin Zheng,et al. Corneal angiography for guiding and evaluating fine-needle diathermy treatment of corneal neovascularization. , 2015, Ophthalmology.
[11] R. Dana,et al. VEGF-trap Aflibercept Significantly Improves Long-term Graft Survival in High-risk Corneal Transplantation , 2015, Transplantation.
[12] R. Dana,et al. Corneal Lymphatics: Role in Ocular Inflammation as Inducer and Responder of Adaptive Immunity , 2014, Journal of clinical & cellular immunology.
[13] Yalin Zheng,et al. Imaging and evaluation of corneal vascularization using fluorescein and indocyanine green angiography. , 2012, Investigative ophthalmology & visual science.
[14] Don Yuen,et al. Combined blockade of VEGFR-3 and VLA-1 markedly promotes high-risk corneal transplant survival. , 2011, Investigative ophthalmology & visual science.
[15] D. Larkin,et al. Sirolimus and mycophenolate as combination prophylaxis in corneal transplant recipients at high rejection risk. , 2010, American journal of ophthalmology.
[16] Claus Cursiefen,et al. Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis. , 2010, Ophthalmology.
[17] D. Larkin,et al. Immune Privilege of Corneal Allografts , 2010, Ocular immunology and inflammation.
[18] S. Wiegand,et al. Cutting Edge: Lymphatic Vessels, Not Blood Vessels, Primarily Mediate Immune Rejections After Transplantation , 2009, The Journal of Immunology.
[19] F. Horn,et al. GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial. , 2009, Ophthalmology.
[20] J. Ambati,et al. Alternatively spliced VEGF receptor-2 is an essential endogenous inhibitor of lymphatic vessels , 2009, Nature Medicine.
[21] D. Coster,et al. Risk Factors for Human Corneal Graft Failure Within the Australian Corneal Graft Registry , 2008, Transplantation.
[22] Y. Chan,et al. Penetrating keratoplasty in Asian eyes: the Singapore Corneal Transplant Study. , 2008, Ophthalmology.
[23] K. Maruyama,et al. Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation. , 2008, Archives of ophthalmology.
[24] D. Sellami,et al. Epidemiology and risk factors for corneal graft rejection. , 2007, Transplantation proceedings.
[25] K. Maruyama,et al. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. , 2004, Investigative ophthalmology & visual science.
[26] D F P Larkin,et al. Corneal Transplantation: The Forgotten Graft , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[27] Robert W. Thompson,et al. Risk factors for various causes of failure in initial corneal grafts. , 2003, Archives of ophthalmology.
[28] P. Wernet,et al. HLA class I and II matching improves prognosis in penetrating normal-risk keratoplasty. , 2003, Developments in ophthalmology.
[29] R. Dana,et al. The critical role of lymph nodes in corneal alloimmunization and graft rejection. , 2001, Investigative ophthalmology & visual science.
[30] S. Gore,et al. Conclusions of the corneal transplant follow up study , 1997, The British journal of ophthalmology.
[31] R. D. Stulting,et al. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. , 1994, Ophthalmology.
[32] D. Roder,et al. Factors predictive of corneal graft survival. Report from the Australian Corneal Graft Registry. , 1992, Ophthalmology.
[33] The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group. , 1992, Archives of ophthalmology.
[34] D. Coster,et al. Leukocytes in the graft bed associated with corneal graft failure. Analysis by immunohistology and actuarial graft survival. , 1989, Ophthalmology.
[35] D. Coster,et al. Report from the Australian Corneal Graft Registry. , 1989, Transplantation proceedings.
[36] S. I. Brown,et al. A follow-up report on transplantation of the alkali-burned cornea. , 1974, American journal of ophthalmology.
[37] G. Smolin,et al. Lymphatic drainage from vascularized rabbit cornea. , 1971, American journal of ophthalmology.